The latest data shows median household financial debt in the North West is the second lowest of any English region.<\/p>
<\/p>
In the UK as a whole, household debt-to-income has increased marginally from 141% 12 months ago to 145% in Q1 2017. This remains significantly below the pre-crisis peak of 160% in Q1 2008.<\/p>
<\/p>
The independent Financial Policy Committee (FPC) was set up by the government to assess and mitigate financial stability risks, including from household debt. The FPC has taken action to ensure against a significant rise in highly indebted households.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4095", "label" : {"_value" : "Biography information for Steve Barclay"} } , "answeringMemberConstituency" : {"_value" : "North East Cambridgeshire"} , "answeringMemberPrinted" : {"_value" : "Stephen Barclay"} , "dateOfAnswer" : {"_value" : "2017-07-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-10T15:45:02.183Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Debts"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, what estimate he has made of the levels of household debt in the (a) Borough of Rochdale and (b) UK in the last 12 months.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4342", "label" : {"_value" : "Biography information for Liz McInnes"} } , "tablingMemberConstituency" : {"_value" : "Heywood and Middleton"} , "tablingMemberPrinted" : [{"_value" : "Liz McInnes"} ], "uin" : "2789"} , {"_about" : "http://data.parliament.uk/resources/748186", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/748186/answer", "answerText" : {"_value" : "
No such estimate has been made. In response to the shortage of piperacillin-tazobactam, the Department has been working with national antimicrobial leads through Public Health England and the Department\u2019s Expert Advisory Group on Antimicrobial Prescribing Resistance and Healthcare Associated Infections who published guidance on appropriate alternative treatment options to ensure that any impact on patient care has been minimised. This guidance provided recommendations on the different broad spectrum antibiotics, or a combination of narrower spectrum antibiotics that can be used to treat the range of infections for which piperacillin-tazobactam is licensed.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2017-07-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-10T14:38:55.497Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Piperacillin/tazobactam: Shortages"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will estimate the potential cost to the NHS of longer (a) treatment times and (b) hospital stays as a result of prescribing less powerful antibiotics as a result of the international shortage of the antibiotic piperacillin-tazobactam.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4342", "label" : {"_value" : "Biography information for Liz McInnes"} } , "tablingMemberConstituency" : {"_value" : "Heywood and Middleton"} , "tablingMemberPrinted" : [{"_value" : "Liz McInnes"} ], "uin" : "2903"} , {"_about" : "http://data.parliament.uk/resources/748212", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/748212/answer", "answerText" : {"_value" : "
The Department is in direct contact with all suppliers of piperacillin-tazobactam about future supplies coming into the United Kingdom, including Pfizer who market the brand Tazocin. Pfizer currently have supplies available and have confirmed that they are able to bring larger volumes of Tazocin to the UK market from October onwards. Several other suppliers of generic piperacillin-tazobactam injection have also confirmed supplies are available and there is no clinical preference between any given manufacturer\u2019s version of the medicine.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2017-07-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-10T15:14:31.25Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Piperacillin/tazobactam"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he plans to take to ensure future supplies of the Tazocin brand of the antibiotic piperacillin-tazobactam.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4342", "label" : {"_value" : "Biography information for Liz McInnes"} } , "tablingMemberConstituency" : {"_value" : "Heywood and Middleton"} , "tablingMemberPrinted" : [{"_value" : "Liz McInnes"} ], "uin" : "2915"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }